These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36988207)

  • 1. Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions.
    Trac N; Ashraf A; Giblin J; Prakash S; Mitragotri S; Chung EJ
    ACS Nano; 2023 Apr; 17(7):6165-6177. PubMed ID: 36988207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.
    Huang Y; Wang J; Jiang K; Chung EJ
    J Control Release; 2021 Jun; 334():127-137. PubMed ID: 33892054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nanotherapy for kidney diseases: a comprehensive review.
    Sabiu G; Kasinath V; Jung S; Li X; Tsokos GC; Abdi R
    Nephrol Dial Transplant; 2023 May; 38(6):1385-1396. PubMed ID: 35945647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering the power of nanomedicine to patients today.
    Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R
    J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.
    Liu CP; Hu Y; Lin JC; Fu HL; Lim LY; Yuan ZX
    Med Res Rev; 2019 Mar; 39(2):561-578. PubMed ID: 30136283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.
    Wang J; Masehi-Lano JJ; Chung EJ
    Biomater Sci; 2017 Jul; 5(8):1450-1459. PubMed ID: 28516997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine tactics in cancer treatment: Challenge and hope.
    Al-Zoubi MS; Al-Zoubi RM
    Crit Rev Oncol Hematol; 2022 Jun; 174():103677. PubMed ID: 35385774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
    Moradi Kashkooli F; Soltani M; Souri M
    J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarrier-based localized and effective treatment of renal disorders: currently employed targeting strategies.
    Ullah S; Burki S; Munir AB; Yousaf G; Shafique M
    Nanomedicine (Lond); 2024 Feb; 19(4):345-361. PubMed ID: 38293889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
    Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
    Pearce AK; O'Reilly RK
    Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy.
    Zhang F; Xu Z; Jolly KJ
    Adv Drug Deliv Rev; 2023 Jun; 197():114827. PubMed ID: 37068659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases.
    Dash S; Das T; Patel P; Panda PK; Suar M; Verma SK
    J Nanobiotechnology; 2022 Aug; 20(1):393. PubMed ID: 36045375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
    Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
    Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.
    Szelenyi I
    Inflamm Res; 2012 Jan; 61(1):1-9. PubMed ID: 22057873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.